Liang Shen, PhD

Original Contribution

Incidence and Predictors of Side-Branch Compromise in Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

07/08/2014

Tiong-Cheng Yeo , MD;

Chi-Hang Lee , MD, MBBS, MRCP;

Valerie Khoo ;

Liang Shen , PhD;

Vanessa Khoo ;

Germaine Loo ;

Mark Richards , MD, PT;

A study to determine the incidence and predictors of side-branch compromise in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction.

A study to determine the...

07/08/2014

Journal of Invasive Cardiology

Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis

BackgroundNeurotrophic tyrosine receptor kinase ( NTRK ) gene fusions are oncogenic drivers in various tumour types. Larotrectinib is a first-in-class, highly selective, central nervous s...

T. Andre ;

D. Hong ;

J. Deeken ;

A. Italiano ;

T. Liu ;

D. Burcoveanu ;

R. Norenberg ;

C. Mussi ;

R. Xu ;

A. Drilon ;

Liang Shen , PhD;

06/25/2023